You can report any suspected side effects directly to the MHRA through the Yellow Card scheme at yellowcard.mhra.gov.uk or via the Yellow Card app
About the Program In our GLP-1 support program, the first Tuesday of every month - GLP-1 Safe and Successful - will focus on need-to-know information for those newly starting a GLP-1 based medication or for those interested in learning more about the considerations of taking these medications
For IP, R&D, and business development teams in the pharma and biotech sectors, as well as the legal and investment professionals who support them, this tension is far more than an academic curiosity
Depending on your history, labs may help your provider assess metabolic health, safety considerations, and whether GLP-1 treatment makes sense
Patients often report sustained energy improvements and mental clarity that correlate with these deeper metabolic shifts
The effectiveness of digital health technologies for patients with diabetes mellitus: a systematic review